back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2020-06-30 17:45 Tx date 2020-06-17 |
$NEPT
Neptune Wellness Solutions Inc. (formerly Neptune Technologies & Bioressources Inc.) |
Bélanger, Jean-Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-49,091
-14,026 vol $3.50 each |
0 | |
| Filed 2020-06-19 08:10 Tx date 2020-06-17 |
$NEPT
Neptune Wellness Solutions Inc. (formerly Neptune Technologies & Bioressources Inc.) |
Bélanger, Jean-Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$49,189
+14,026 vol $3.51 each |
14,026 | |
| Filed 2020-06-19 08:09 Tx date 2020-06-17 |
$NEPT
Neptune Wellness Solutions Inc. (formerly Neptune Technologies & Bioressources Inc.) |
Bélanger, Jean-Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-19,075.36
-14,026 vol $1.36 each |
456,000 | |
| Filed 2019-11-28 10:55 Tx date 2019-11-22 |
$NEPT
Neptune Wellness Solutions Inc. (formerly Neptune Technologies & Bioressources Inc.) |
Bélanger, Jean-Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-112,168.40
-29,518 vol $3.80 each |
0 | |
| Filed 2019-11-27 16:20 Tx date 2019-11-22 |
$NEPT
Neptune Wellness Solutions Inc. (formerly Neptune Technologies & Bioressources Inc.) |
Bélanger, Jean-Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-110,302.60
-29,027 vol $3.80 each |
||
| Filed 2019-11-27 16:20 Tx date 2019-11-22 |
$NEPT
Neptune Wellness Solutions Inc. (formerly Neptune Technologies & Bioressources Inc.) |
Bélanger, Jean-Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-110,302.60
-29,027 vol $3.80 each |
491 | |
| Filed 2019-11-27 16:17 Tx date 2019-11-22 |
$NEPT
Neptune Wellness Solutions Inc. (formerly Neptune Technologies & Bioressources Inc.) |
Bélanger, Jean-Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
+29,027 vol |
29,518 | |
| Filed 2019-11-27 16:17 Tx date 2019-11-22 |
$NEPT
Neptune Wellness Solutions Inc. (formerly Neptune Technologies & Bioressources Inc.) |
Bélanger, Jean-Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-19,076.72
-14,027 vol $1.36 each |
485,026 | |
| Filed 2019-11-27 16:17 Tx date 2019-11-22 |
$NEPT
Neptune Wellness Solutions Inc. (formerly Neptune Technologies & Bioressources Inc.) |
Bélanger, Jean-Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-24,450
-15,000 vol $1.63 each |
470,026 | |
| Filed 2019-11-27 16:14 Tx date 2019-11-23 |
$NEPT
Neptune Wellness Solutions Inc. (formerly Neptune Technologies & Bioressources Inc.) |
Bélanger, Jean-Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-24,450
-15,000 vol $1.63 each |
||
| Filed 2019-11-27 16:10 Tx date 2019-11-23 |
$NEPT
Neptune Wellness Solutions Inc. (formerly Neptune Technologies & Bioressources Inc.) |
Bélanger, Jean-Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
+29,027 vol |
||
| Filed 2019-11-27 16:06 Tx date 2019-11-23 |
$NEPT
Neptune Wellness Solutions Inc. (formerly Neptune Technologies & Bioressources Inc.) |
Bélanger, Jean-Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-24,450
-15,000 vol $1.63 each |
||
| Filed 2019-11-27 16:01 Tx date 2019-11-23 |
$NEPT
Neptune Wellness Solutions Inc. (formerly Neptune Technologies & Bioressources Inc.) |
Bélanger, Jean-Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-24,450
-15,000 vol $1.63 each |
||
| Filed 2019-11-27 16:00 Tx date 2019-11-23 |
$NEPT
Neptune Wellness Solutions Inc. (formerly Neptune Technologies & Bioressources Inc.) |
Bélanger, Jean-Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-19,076.72
-14,027 vol $1.36 each |
||
| Filed 2018-06-27 Tx date 2018-06-21 |
$NEPT
Neptune Technologies & Bioressources Inc. |
Bélanger, Jean-Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
+186,026 vol |
||
| Filed 2018-06-27 Tx date 2018-06-21 |
$NEPT
Neptune Technologies & Bioressources Inc. |
Bélanger, Jean-Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$297,269
+186,026 vol $1.60 each |
186,491 | |
| Filed 2018-06-27 Tx date 2018-06-21 |
$NEPT
Neptune Technologies & Bioressources Inc. |
Bélanger, Jean-Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-186,026 vol |
||
| Filed 2018-06-27 Tx date 2018-06-21 |
$NEPT
Neptune Technologies & Bioressources Inc. |
Bélanger, Jean-Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-297,269.548
-186,026 vol $1.60 each |
499,053 | |
| Filed 2018-06-26 Tx date 2018-06-21 |
$NEPT
Neptune Technologies & Bioressources Inc. |
Bélanger, Jean-Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-186,026 vol |
499,053 | |
| Filed 2018-06-26 Tx date 2018-06-21 |
$NEPT
Neptune Technologies & Bioressources Inc. |
Bélanger, Jean-Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
+186,026 vol |
186,491 | |
| Filed 2018-06-26 Tx date 2018-06-21 |
$NEPT
Neptune Technologies & Bioressources Inc. |
Bélanger, Jean-Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,000,680
-186,000 vol $5.38 each |
491 | |
| Filed 2017-12-11 Tx date 2017-12-06 |
$NEPT
Neptune Technologies & Bioressources Inc. |
Bélanger, Jean-Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$601,920
+304,000 vol $1.98 each |
533,079 | |
| Filed 2017-12-11 Tx date 2017-12-06 |
$NEPT
Neptune Technologies & Bioressources Inc. |
Bélanger, Jean-Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$300,960
+152,000 vol $1.98 each |
685,079 | |
| Filed 2017-11-23 Tx date 2017-11-21 |
$ACST
Acasti Pharma Inc. |
Bélanger, Jean-Daniel
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
|
$-123,389.59
-51,199 vol $2.41 each |
||
| Filed 2017-11-23 Tx date 2017-08-15 |
$ACST
Acasti Pharma Inc. |
Bélanger, Jean-Daniel
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares (Actions de catégorie A)
00 - Opening Balance-Initial SEDI Report
|
51,199 | ||
| Filed 2017-11-23 Tx date 2017-11-20 |
$ACST
Acasti Pharma Inc. |
Bélanger, Jean-Daniel
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
|
$-123,389.59
-51,199 vol $2.41 each |
0 | |
| Filed 2017-08-30 Tx date 2017-06-27 |
$NEPT
Neptune Technologies & Bioressources Inc. |
Bélanger, Jean-Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants NeuroBio Exchanged Warrants
55 - Expiration of warrants
|
$-24,983
-1,162 vol $21.50 each |
0 | |
| Filed 2017-08-30 Tx date 2017-06-27 |
$NEPT
Neptune Technologies & Bioressources Inc. |
Bélanger, Jean-Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Call-options
52 - Expiration of options
|
$-75,000
-2,500 vol $30.00 each |
0 | |
| Filed 2017-04-12 Tx date 2017-04-07 |
$NEPT
Neptune Technologies & Bioressources Inc. |
Bélanger, Jean-Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$57,227
+42,079 vol $1.36 each |
229,079 | |
| Filed 2017-03-01 Tx date 2017-02-28 |
$ACST
Acasti Pharma Inc. |
Bélanger, Jean-Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market
|
$-14,210.07
-9,051 vol $1.57 each |
51,199 | |
| Filed 2017-03-01 Tx date 2017-02-24 |
$ACST
Acasti Pharma Inc. |
Bélanger, Jean-Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Actions de catégorie A)
97 - Other
|
$94,200
+60,000 vol $1.57 each |
60,250 | |
| Filed 2016-06-21 Tx date 2016-04-12 |
$NTB
Neptune Technologies & Bioressources Inc. |
Bélanger, Jean-Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants NeuroBio Exchanged Warrants
55 - Expiration of warrants
|
$-18,731.44
-1,162 vol $16.12 each |
1,162 | |
| Filed 2016-06-01 Tx date 2016-05-30 |
$NTB
Neptune Technologies & Bioressources Inc. |
Bélanger, Jean-Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$73,350
+45,000 vol $1.63 each |
187,000 | |
| Filed 2015-12-03 Tx date 2015-12-02 |
$NTB
Neptune Technologies & Bioressources Inc. |
Bélanger, Jean-Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Call-options
52 - Expiration of options
|
$-68,750
-2,500 vol $27.50 each |
2,500 | |
| Filed 2015-12-03 Tx date 2015-12-02 |
$NTB
Neptune Technologies & Bioressources Inc. |
Bélanger, Jean-Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants NeuroBio Exchanged Warrants
55 - Expiration of warrants
|
$-18,737.25
-1,162 vol $16.13 each |
2,324 | |
| Filed 2015-12-03 Tx date 2015-12-02 |
$NTB
Neptune Technologies & Bioressources Inc. |
Bélanger, Jean-Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-145,000
-50,000 vol $2.90 each |
142,000 | |
| Filed 2015-11-09 Tx date 2015-10-25 |
$NTB
Neptune Technologies & Bioressources Inc. |
Bélanger, Jean-Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-100,000
-25,000 vol $4.00 each |
192,000 | |
| Filed 2015-11-03 Tx date 2015-10-15 |
$APO
Acasti Pharma Inc. |
Bélanger, Jean-Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Actions de catégorie A)
37 - Stock split or consolidation
|
-2,250 vol |
250 | |
| Filed 2015-11-03 Tx date 2015-10-15 |
$APO
Acasti Pharma Inc. |
Bélanger, Jean-Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-64,800 vol |
7,200 | |
| Filed 2015-11-03 Tx date 2015-10-25 |
$APO
Acasti Pharma Inc. |
Bélanger, Jean-Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-62,500
-25,000 vol $2.50 each |
||
| Filed 2015-11-03 Tx date 2015-10-25 |
$APO
Acasti Pharma Inc. |
Bélanger, Jean-Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-62,500
-25,000 vol $2.50 each |
||
| Filed 2015-11-03 Tx date 2015-10-25 |
$APO
Acasti Pharma Inc. |
Bélanger, Jean-Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-2,500 vol |
4,700 | |
| Filed 2015-11-03 Tx date 2015-10-15 |
$NTB
Neptune Technologies & Bioressources Inc. |
Bélanger, Jean-Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Call-options
37 - Stock split or consolidation
|
-45,000 vol |
5,000 | |
| Filed 2015-10-22 Tx date 2015-10-16 |
$NTB
Neptune Technologies & Bioressources Inc. |
Bélanger, Jean-Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$77,500
+50,000 vol $1.55 each |
||
| Filed 2015-10-22 Tx date 2015-10-16 |
$NTB
Neptune Technologies & Bioressources Inc. |
Bélanger, Jean-Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$77,500
+50,000 vol $1.55 each |
217,000 | |
| Filed 2015-10-21 Tx date 2015-10-16 |
$NTB
Neptune Technologies & Bioressources Inc. |
Bélanger, Jean-Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$77,500
+50,000 vol $1.55 each |
217,000 | |
| Filed 2015-06-17 Tx date 2015-06-15 |
$APO
Acasti Pharma Inc. |
Bélanger, Jean-Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Actions de catégorie A)
57 - Exercise of rights
|
$900.00
+2,500 vol $0.36 each |
2,500 | |
| Filed 2015-06-16 Tx date 2015-06-15 |
$APO
Acasti Pharma Inc. |
Bélanger, Jean-Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-900.00
-2,500 vol $0.36 each |
0 | |
| Filed 2015-06-08 Tx date 2015-06-01 |
$APO
Acasti Pharma Inc. |
Bélanger, Jean-Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$21,150
+47,000 vol $0.45 each |
72,000 | |
| Filed 2015-06-08 Tx date 2015-06-01 |
$NTB
Neptune Technologies & Bioressources Inc. |
Bélanger, Jean-Daniel
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$69,300
+42,000 vol $1.65 each |
167,000 |